Lexeo Therapeutics, Inc. (LXEO) stock
Close on Nov 13, 2026Market cap $235.47MP/E –Yield –
Lexeo Therapeutics statistics
68 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.00
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 113.1%
- 10.8%
- Shares Change (QoQ)
- 6.12%
- 0.49%
- Float
- 81M
- 49M
- Shares Held by Insiders
- 1.18%
- 11.6%
- Shares Held by Institutions
- 109.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 17M
- –
- Short Interest Change
- -2.94%
- -0.80%
- Short % of Float
- 21.0%
- 8.98%
- Short % of Shares Outstanding
- 20.8%
- 6.30%
- Days to Cover
- 12.73
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $10.99
- –
- 52-Week Low
- $2.55
- –
- 20-Day Moving Average
- $2.98
- –
- 50-Day Moving Average
- $3.38
- –
- 200-Day Moving Average
- $4.99
- –
- Average True Range (14)
- $0.28
- –
- Price Change (1 Week)
- -0.69%
- -1.15%
- Price Change (1 Month)
- 3.99%
- -4.86%
- Price Change (3 Months)
- -42.4%
- -21.1%
- Price Change (6 Months)
- -43.6%
- -20.7%
- Price Change (YTD)
- -71.1%
- -23.6%
- Price Change (1 Year)
- -68.8%
- -22.7%
- Price Change (3 Years)
- -72.8%
- -29.5%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.36
- 0.70
- Relative Strength Index (14)
- 42.5
- 43.4
- Volatility (1 Year)
- 70.9%
- 80.1%
- Beta (5 Years)
- 2.16
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -46.8%
- -50.3%
- Return on Assets (ROA)
- -40.5%
- -40.6%
- Return on Invested Capital (ROIC)
- -5115.2%
- -33.1%
- Return on Capital Employed (ROCE)
- -39.8%
- -38.0%
Financial positionIndustry
- Current Ratio
- 13.89
- 3.30
- Quick Ratio
- 14.92
- 2.39
- Interest Coverage
- -1302.97
- -6.31
EfficiencyIndustry
- Profits Per Employee
- -$1.48M
- -$690.06K
- Employee Count
- 59
- 75
- WACC
- 15.9%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$86.97M
- -$12.98M
Balance sheetIndustry
- Net Cash (Debt)
- $234.20M
- $17.80M
- Net Cash Per Share
- $2.85
- $0.80
- Equity (Book Value)
- $235.06M
- $53.27M
- Book Value Per Share
- $2.86
- $1.50
- Tangible Book Value
- $235.06M
- $26.82M
- Working Capital
- $202.22M
- $79.93M
Cash flow (TTM)Industry
- Capital Expenditures
- -$331.00K
- -$1.00M
- FCF Per Share
- -$1.08
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -37.1%
- -22.0%
- FCF Yield
- -37.7%
- -9.44%
- Buyback Yield
- -10.7%
- -0.76%
- Shareholder Yield
- -10.7%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $73.00K
- $2.93M
Scores and fair valueIndustry
- Altman Z-Score
- 4.50
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | LXEO | S&P 500 | Difference | LXEO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.7% | -3.0% | +7.8 pts | ||
| 3 months | -42.1% | -2.8% | −39.4 pts | ||
| Year to date | -71.1% | +11.5% | −82.6 pts | ||
| 1 year | -68.1% | +13.5% | −81.5 pts | ||
| 3 years | -72.7% | +77.7% | −150.4 pts | -35.1% | +21.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
17M LXEO shares were sold short on Oct 30, 2026, down 2.9% from the previous report, or 21.01% of the shares available to trade. At recent volumes it would take 12.7 days to buy them back. Over the last 20 sessions, 50.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 17,037,063 | -2.9% | 1,338,371 | 12.7 |
| Oct 15, 2026 | 17,553,163 | -8.8% | 1,747,729 | 10.0 |
| Sep 30, 2026 | 19,246,976 | -6.7% | 2,129,601 | 9.0 |
| Sep 15, 2026 | 20,627,916 | +0.7% | 616,778 | 33.4 |
| Aug 31, 2026 | 20,485,477 | +0.0% | 763,910 | 26.8 |
| Aug 14, 2026 | 20,477,587 | +20.1% | 1,035,720 | 19.8 |
| Jul 31, 2026 | 17,054,582 | +4.3% | 1,010,878 | 16.9 |
| Jul 15, 2026 | 16,348,536 | +1.4% | 836,123 | 19.6 |
| Jun 30, 2026 | 16,129,164 | +14.5% | 1,150,335 | 14.0 |
| Jun 15, 2026 | 14,088,171 | +2.3% | 748,947 | 18.8 |
| May 29, 2026 | 13,775,211 | +4.3% | 793,543 | 17.4 |
| May 15, 2026 | 13,212,896 | +1.1% | 702,022 | 18.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?